Home Current concepts in standardization of cardiac marker immunoassays
Article
Licensed
Unlicensed Requires Authentication

Current concepts in standardization of cardiac marker immunoassays

  • Mauro Panteghini
Published/Copyright: June 1, 2005

Abstract

Cardiac markers are measured by a number of different immunoassays using specific antibodies directed to the respective antigens. Lacking assay standardization, different results from different assays measuring the same marker may be obtained and this problem may cloud interpretations of reported data. Presently, there are no reference procedures for cardiac markers; certified reference materials should still be established and, at least for cardiac troponins, the analyte in the patients' blood is significantly different from newly synthesized protein. It is therefore clear that the problems of cardiac marker standardization will not be quickly solved. A number of projects are, however, underway under the auspices of the IFCC and other organizations. The aim of this opinion is to reflect on some concepts related to the implementation of a metrologically correct measurement system, giving practical examples on how these concepts can be applied to immunoassays measuring cardiac markers.

Published Online: 2005-6-1
Published in Print: 2004-2-16

Copyright © 2004 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. International collaboration in clinical chemistry and laboratory medicine: the Human Proteome Organization (HUPO) Plasma Proteome Project
  2. Current concepts in standardization of cardiac marker immunoassays
  3. Collagen, ageing and nutrition
  4. Evaluation of a new efficient procedure for single-nucleotide polymorphism genotyping: tetra-primer amplification refractory mutation system-polymerase chain reaction
  5. High prevalence of non-HFE gene-associated haemochromatosis in patients from southern Italy
  6. Limited usefulness of the PFA-100™ for the monitoring of ADP receptor antagonists–in vitro experience
  7. Isolation of plasma small-dense low-density lipoprotein using a simple air-driven ultracentrifuge and quantification using immunassay of apolipoprotein B
  8. Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide
  9. Calcium oxalate crystallization in untreated urine, centrifuged and filtered urine and ultrafiltered urine
  10. Matrix effects in clinical immunoassays and the effect of preheating and cooling analytical samples
  11. Blood alcohol testing: comparison of the performance obtained with the different methods used in the Belgian external quality assessment schemes
  12. Determination of lipase catalytic activity in two reference materials: BCR 693 and BCR 694 by titrimetry at constant pH
  13. Evaluation of a new generation of plastic evacuated blood-collection tubes in clinical chemistry, therapeutic drug monitoring, hormone and trace metal analysis
  14. Association between the CYP2C9 polymorphism and the drug metabolism phenotype
  15. Analytical goals for coagulation tests based on biological variation
  16. In vivo total antioxidant capacity: comparison of two different analytical methods
  17. Performance evaluation of automated assays for β-CrossLaps, N-MID-Osteocalcin and intact parathyroidhormone (BIOROSE Multicenter Study)
  18. Evaluation of the blood gas analyzer GEM(r) PREMIER(tm) 3000
  19. Lactate dehydrogenase (LD) extra isoenzyme electrophoretic band between LD1 and LD2 caused by a complex with α1-lipoprotein. A case report
  20. Relationship between cryoglobulins and hepatitis C virus (HCV) core antigen or antibody titers
  21. Spurious hyperphosphatemia due to sample contamination with heparinized saline from an indwelling catheter
  22. Biological variation of plasma chromogranin A
  23. Verification, validation and evaluation of analytical procedures in laboratory medicine
  24. DACH-LIGA Homocystein (German, Austrian and Swiss Homocysteine Society): Consensus Paper on the Rational Clinical Use of Homocysteine, Folic Acid and B-Vitamins in Cardiovascular and Thrombotic Diseases: Guidelines and Recommendations
  25. Meetings and Awards
Downloaded on 12.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2004.002/html
Scroll to top button